Congenital Central Hypoventilation Syndrome: Diagnosis and Long-Term Ventilatory Outcomes.

• Type of Material: Article
• Authors: Mary Ellen Fain, Emory University; Adrianna L Westbrook, Emory University; Ajay Kasi, Emory University
• Language: English
• Date: 2023
• Publisher: SAGE Publications Ltd
• Publication Version: Final Published Version
• Copyright Statement: © The Author(s) 2023.
• Final Published Version (URL): http://dx.doi.org/10.1177/11795565231169556
• Title of Journal or Parent Work: Clin Med Insights Pediatr
• Volume: 17
• Start Page: 11795565231169556
• End Page: 11795565231169556
• Grant/Funding Information: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
• Keywords: home ventilation; central sleep apnea; diaphragm pacing; tracheostomy; PHOX2B; Congenital central hypoventilation syndrome

Abstract

BACKGROUND: Congenital central hypoventilation syndrome (CCHS), a rare disease caused by variants in the paired-like homeobox 2B (PHOX2B) gene, affects regulation of respiration necessitating lifelong assisted ventilation (AV). Most patients require full-time AV during infancy and some patients may sustain adequate spontaneous ventilation during wakefulness and change AV modalities at a later age. The aims of this study were to assess the changes in duration and modalities of AV, long-term respiratory outcomes, and to correlate them with PHOX2B genotypes. METHODS: We conducted a retrospective study of patients with CCHS treated at our institution between January 1997 and May 2022. Results analyzed included: clinical presentation, PHOX2B genotype, modality and duration of AV at diagnosis and follow-up, survival, and transition to adult care. RESULTS: We identified 30 patients with CCHS-8 with PHOX2B nonpolyalanine repeat mutations (NPARMs), 21 with polyalanine repeat mutations (PARMs), and 1 with unknown PHOX2B genotype. The median age at presentation was 0.25 months (IQR 0.1-0.7 months). At diagnosis of CCHS, 24 (80%) patients required continuous AV and 28 (93%) received AV via tracheostomy. Twenty-six patients required sleep-only AV at a median age of 9 months (IQR 6-14 months). Nine patients requiring sleep-only AV underwent tracheostomy decannulation at a median age of 11.2 years (IQR 5.9-15.7 years) and used noninvasive positive pressure ventilation or diaphragm pacing. There was insufficient evidence to conclude that patients with PARMs and NPARMs differed by age at presentation (P = .39), tracheostomy (P = .06), and transition to sleep-only AV (P = .9). Six patients transitioned to adult care, 23 continued receiving pediatric care, and 1 patient died due to complications from Hirschsprung's disease. CONCLUSION: Our study demonstrates prolonged survival and good long-term respiratory outcomes possibly related to the early diagnosis of CCHS, optimizing AV strategies, and multidisciplinary care. The increasing number of patients attaining adulthood highlights the necessity for multidisciplinary care for adults with CCHS.